Livagen.
About Livagen
Livagen is studied in tissue regeneration and repair research, including cell and animal models. In lymphocytes from older people, Livagen activated ribosomal genes and produced decondensation of pericentromeric and telomeric heterochromatin; in hepatocyte cultures from old rats it markedly increased protein synthesis.
Research Application
Researched as a liver bioregulator, with reports of increased protein synthesis in aged hepatocytes and effects on digestive enzymes. The evidence base is comparatively extensive for this peptide family but remains preclinical.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
Studies on regenerative peptides are mostly derived from cell culture and animal models; comprehensive clinical data is typically still limited.
- Khavinson VKh, Lezhava TA, et al. Bull Exp Biol Med. 2002;134(4):389–392. PMID 12533768
- Timofeeva NM, Khavinson VKh, et al. Adv Gerontol. 2005;16:92–96. PMID 16075683
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Similar Peptides
Question about Livagen?
We reply personally – via email or Telegram.